Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 and Conjunctive Melanoma (CM)

<< Previous

Bullboard Posts

Next >>

Comment by tamarindo1on Sep 21, 2021 1:24pm

406 Views

Post# 33892824

RE:RE:RE:RE:RE:TLD1433 and Conjunctive Melanoma (CM)

99942Apophis wrote: Thanks socks for that chuckle, that fictional list would be extremely long with perhaps names like IBM?
Anyone else with names to contribute to this fictional list, please add your candidate.

This was last February: maybe we can make eyes at him. :-))